The Oncology Institute, Inc. (TOI) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Care Facilities Branche. Der Hauptsitz des Unternehmens ist in Cerritos, CA, United States. Der aktuelle CEO ist Daniel Virnich.
TOI hat IPO-Datum 2020-06-04, 825 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $339.02M.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
